| Autor: |
Dargad, Ramesh R., Prajapati, Mahesh R., Dargad, Rohit R., Parekh, Jai D. |
| Zdroj: |
Indian Heart Journal; July 2018, Vol. 70 Issue: 1, Number 1 Supplement 1 pS102-S110, 9p |
| Abstrakt: |
To describe the efficacy, superiority and safety profile of the first-in-class angiotensin receptor-neprilysin inhibitor “Sacubitril/Valsartan” as compared to angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blocker (ARB) in heart failure (HF) patients, reviewing data available from both clinical and pre-clinical studies. Evidences on health care utilization outcomes such as hospitalizations and emergency department visits were also evaluated. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
